Great West Life Assurance Co. Can grew its position in shares of GRIFOLS S A/S (NASDAQ:GRFS) by 16.2% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 540,365 shares of the biotechnology company’s stock after buying an additional 75,418 shares during the period. Great West Life Assurance Co. Can owned about 0.08% of GRIFOLS S A/S worth $11,591,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Verition Fund Management LLC raised its position in shares of GRIFOLS S A/S by 23.2% during the 2nd quarter. Verition Fund Management LLC now owns 18,818 shares of the biotechnology company’s stock worth $405,000 after purchasing an additional 3,539 shares during the period. Keybank National Association OH increased its position in shares of GRIFOLS S A/S by 8.5% during the 3rd quarter. Keybank National Association OH now owns 46,807 shares of the biotechnology company’s stock valued at $1,000,000 after purchasing an additional 3,664 shares during the period. BNP Paribas Arbitrage SA increased its position in shares of GRIFOLS S A/S by 14.3% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 34,055 shares of the biotechnology company’s stock valued at $732,000 after purchasing an additional 4,255 shares during the period. Wells Fargo & Company MN increased its position in shares of GRIFOLS S A/S by 2.5% during the 3rd quarter. Wells Fargo & Company MN now owns 215,749 shares of the biotechnology company’s stock valued at $4,611,000 after purchasing an additional 5,327 shares during the period. Finally, Todd Asset Management LLC increased its position in shares of GRIFOLS S A/S by 0.6% during the 2nd quarter. Todd Asset Management LLC now owns 975,898 shares of the biotechnology company’s stock valued at $20,982,000 after purchasing an additional 5,426 shares during the period. 20.17% of the stock is currently owned by institutional investors.

Several equities analysts have recently issued reports on the company. Zacks Investment Research cut GRIFOLS S A/S from a “hold” rating to a “sell” rating in a research report on Tuesday, October 2nd. Morgan Stanley lowered their price target on GRIFOLS S A/S from $22.00 to $20.00 and set an “underweight” rating on the stock in a research report on Monday, October 1st. BidaskClub upgraded GRIFOLS S A/S from a “sell” rating to a “hold” rating in a research report on Wednesday, September 19th. Santander upgraded GRIFOLS S A/S from an “underperform” rating to a “hold” rating in a research report on Tuesday, October 30th. Finally, Berenberg Bank upgraded GRIFOLS S A/S from a “hold” rating to a “buy” rating in a research report on Thursday, October 11th. Three equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and three have issued a buy rating to the company. GRIFOLS S A/S presently has a consensus rating of “Hold” and a consensus price target of $21.50.

Shares of GRFS stock opened at $19.51 on Friday. The firm has a market cap of $13.20 billion, a PE ratio of 17.74, a PEG ratio of 1.39 and a beta of 1.12. The company has a debt-to-equity ratio of 1.47, a quick ratio of 1.07 and a current ratio of 2.78. GRIFOLS S A/S has a 1 year low of $17.47 and a 1 year high of $25.18.

The business also recently disclosed a special dividend, which will be paid on Tuesday, December 11th. Stockholders of record on Monday, December 3rd will be paid a dividend of $0.2283 per share. The ex-dividend date of this dividend is Friday, November 30th. This is a positive change from GRIFOLS S A/S’s previous special dividend of $0.01. This represents a dividend yield of 2.25%. GRIFOLS S A/S’s dividend payout ratio (DPR) is currently 31.82%.

ILLEGAL ACTIVITY NOTICE: “GRIFOLS S A/S (GRFS) Shares Bought by Great West Life Assurance Co. Can” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The legal version of this story can be read at https://www.thecerbatgem.com/2018/12/07/grifols-s-a-s-grfs-shares-bought-by-great-west-life-assurance-co-can.html.

About GRIFOLS S A/S

Grifols, SA, a specialty pharmaceutical company, develops, manufactures, and distributes biological medicines on plasma derived proteins in the United States, Canada, Spain, rest of the European Union, and internationally. The company operates through five segments: Bioscience, Diagnostic, Hospital, Bio Supplies, and Others.

Featured Story: Cost of equity and a company’s balance sheet

Institutional Ownership by Quarter for GRIFOLS S A/S (NASDAQ:GRFS)

Receive News & Ratings for GRIFOLS S A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GRIFOLS S A/S and related companies with MarketBeat.com's FREE daily email newsletter.